Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bubenik

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Oncology Reports|May 19, 2011
Tumour inhibitory effects of plasmid DNAJ Simova, J Bubenik, P Rossner, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1990
Down-regulation of LAK cell-mediated cytotoxicity: cancer and ageingS N Bykovskaya, I F Abronina, T A Kupriyanova, et al.
International Journal of Oncology|May 10, 2011
IFN-alpha therapy of renal-cell carcinoma - defect of lymphocyte sensitivity to mitogenic and activating cytokine signals in patients not-responding to therapyM Indrova, J Bubenik, J Jakoubkova, et al.
Journal of the American Veterinary Medical Association|September 18, 2007
Frequency of urinary tract infection in catheterized dogs and comparison of bacterial culture and susceptibility testing results for catheterized and noncatheterized dogs with urinary tract infectionsLoretta J Bubenik, Giselle L Hosgood, Don R Waldron, et al.
International Journal of Oncology|February 12, 1998
Immunogenicity, immunosensitivity and cell surface adhesiveness of tumour vaccines carrying an inserted CD80 geneM Indrova, J Bubenik, P Rossner, et al.
International Journal of Oncology|April 30, 2011
Tumour vaccines expressing IL-2, CD80, and IL-2 plus CD80 geneJ Bubenik, P Rossner, D Bubenikova, et al.
Journal of Biological Regulators and Homeostatic Agents|January 6, 2012
Effects of 5-azacytidine and trichostatin A on dendritic cell maturationI Stepanek, M Indrova, J Bieblova, et al.
International Journal of Oncology|May 6, 2011
IL-2 as adjuvant for vaccination with cells malignantly converted by HPV 16 or 3-MCJ Bubenik, J Simova, P Vondrys, et al.
Clinical & Experimental Metastasis|November 2, 2001
Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastasesR Mikysková, J Bubenik, L Mendoza, et al.
Voprosy Virusologii|January 1, 1983
[Biological characteristics of lymphoid cell lines producing lymphotropic primate herpesviruses]V Z Agrba, F D Onishchuk, J Bubenik, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Oncology Reports|May 19, 2011
Tumour inhibitory effects of plasmid DNAJ Simova, J Bubenik, P Rossner, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1990
Down-regulation of LAK cell-mediated cytotoxicity: cancer and ageingS N Bykovskaya, I F Abronina, T A Kupriyanova, et al.
International Journal of Oncology|May 10, 2011
IFN-alpha therapy of renal-cell carcinoma - defect of lymphocyte sensitivity to mitogenic and activating cytokine signals in patients not-responding to therapyM Indrova, J Bubenik, J Jakoubkova, et al.
Journal of the American Veterinary Medical Association|September 18, 2007
Frequency of urinary tract infection in catheterized dogs and comparison of bacterial culture and susceptibility testing results for catheterized and noncatheterized dogs with urinary tract infectionsLoretta J Bubenik, Giselle L Hosgood, Don R Waldron, et al.
International Journal of Oncology|February 12, 1998
Immunogenicity, immunosensitivity and cell surface adhesiveness of tumour vaccines carrying an inserted CD80 geneM Indrova, J Bubenik, P Rossner, et al.
International Journal of Oncology|April 30, 2011
Tumour vaccines expressing IL-2, CD80, and IL-2 plus CD80 geneJ Bubenik, P Rossner, D Bubenikova, et al.
Journal of Biological Regulators and Homeostatic Agents|January 6, 2012
Effects of 5-azacytidine and trichostatin A on dendritic cell maturationI Stepanek, M Indrova, J Bieblova, et al.
International Journal of Oncology|May 6, 2011
IL-2 as adjuvant for vaccination with cells malignantly converted by HPV 16 or 3-MCJ Bubenik, J Simova, P Vondrys, et al.
Clinical & Experimental Metastasis|November 2, 2001
Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastasesR Mikysková, J Bubenik, L Mendoza, et al.
Voprosy Virusologii|January 1, 1983
[Biological characteristics of lymphoid cell lines producing lymphotropic primate herpesviruses]V Z Agrba, F D Onishchuk, J Bubenik, et al.
Pageof 3